Cutting Copays Act
HR 4139, the Cutting Copays Act, lowers out-of-pocket prescription drug costs for low-income Medicare Part D beneficiaries. It reduces the maximum copay for generic drugs to $0 starting in 2026 and caps copays for other drugs at $3 before 2026, with future adjustments tied to inflation. The bill directly affects Medicare Part D enrollees who qualify for low-income subsidies, ensuring their annual drug costs stay below set limits. These changes modify existing Medicare Part D cost-sharing rules without creating new programs or altering eligibility.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2025
Committee Review
Floor Vote
President
Introduced Jun 25, 2025
Last action Jun 25, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jun 25, 2025
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Jun 25, 2025
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 4139
Scope: US
Hi! I can help you understand HR 4139. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline